When it comes to treatment for chronic rhinosinusitis, it’s not the drug that’s the problem, but rather finding a way…More
In the case of developing drugs, while DSP-1181 may have been the first, scientists are convinced it is far from…More
Traditional pharmacies are adapting to the rapidly changing healthcare scene by shifting their priorities to patient care.More
Dogged for months by concerns over manufacturing, Bluebird Bio’s ultra-pricey flagship gene therapy Zynteglo was finally cleared for launch in…More
Drugmakers usually target two things: pricing and volume, hopefully both at the same time. But when prices go down, volume’s…More
An industrywide price-fixing probe has snared another former exec—this time a big fish at Novartis’ generics business, Sandoz. Hector Armando Kellum,…More
Merck’s Keytruda may be pressuring Bristol-Myers Squibb’s Opdivo in kidney cancer in the U.S. But in England, cost watchdogs won’t…More
In his budget for next year, President Donald Trump calls for an out-of-pocket cap for patients in Medicare Part D, improving…More
Utah is sending employees to Mexico to save on drug costs making clear states are willing to get creative to…More
In a long-running price-fixing probe into some of the generics industry’s biggest players, federal prosecutors have seen modest returns so far…More
